Li, Xian <br/><br/>
Systematic combination screening reveals synergism between rapamycin and sunitinib against human lung cancer.  [electronic resource] 

 -  Cancer letters  Jan 2014 
 - 159-66 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1872-7980 
<br/><br/><label>Standard No.: </label>10.1016/j.canlet.2013.08.046  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Angiogenesis Inhibitors--pharmacology<br/>Animals<br/>Carcinoma, Non-Small-Cell Lung--blood supply<br/>Cell Line, Tumor--drug effects<br/>Cell Proliferation--drug effects<br/>Chick Embryo<br/>Chorioallantoic Membrane--blood supply<br/>Drug Screening Assays, Antitumor--methods<br/>Drug Synergism<br/>G1 Phase Cell Cycle Checkpoints<br/>Gene Expression--drug effects<br/>Human Umbilical Vein Endothelial Cells--drug effects<br/>Humans<br/>Hypoxia-Inducible Factor 1, alpha Subunit--genetics<br/>Indoles--pharmacology<br/>Inhibitory Concentration 50<br/>Lung Neoplasms--blood supply<br/>Phosphorylation<br/>Protein Processing, Post-Translational--drug effects<br/>Proto-Oncogene Proteins c-akt--metabolism<br/>Pyrroles--pharmacology<br/>Rats<br/>Rats, Sprague-Dawley<br/>Signal Transduction<br/>Sirolimus--pharmacology<br/>Sunitinib<br/>TOR Serine-Threonine Kinases--metabolism<br/>Tissue Culture Techniques<br/>Vascular Endothelial Growth Factor A--metabolism